These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10472533)

  • 1. Medium-chain triglyceride loading test in carnitine-acylcarnitine translocase deficiency: insights on treatment.
    Parini R; Invernizzi F; Menni F; Garavaglia B; Melotti D; Rimoldi M; Salera S; Tosetto C; Taroni F
    J Inherit Metab Dis; 1999 Aug; 22(6):733-9. PubMed ID: 10472533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial carnitine-acylcarnitine translocase deficiency presenting as sudden neonatal death.
    Chalmers RA; Stanley CA; English N; Wigglesworth JS
    J Pediatr; 1997 Aug; 131(2):220-5. PubMed ID: 9290607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carnitine-acylcarnitine translocase deficiency with severe hypoglycemia and auriculo ventricular block. Translocase assay in permeabilized fibroblasts.
    Pande SV; Brivet M; Slama A; Demaugre F; Aufrant C; Saudubray JM
    J Clin Invest; 1993 Mar; 91(3):1247-52. PubMed ID: 8450053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired peroxisomal fatty acid oxidation in human skin fibroblasts with a mitochondrial acylcarnitine/carnitine translocase deficiency.
    Jakobs BS; Wanders RJ
    J Inherit Metab Dis; 1996; 19(2):185-7. PubMed ID: 8739961
    [No Abstract]   [Full Text] [Related]  

  • 5. Peroxisomes contribute to the acylcarnitine production when the carnitine shuttle is deficient.
    Violante S; Ijlst L; Te Brinke H; Koster J; Tavares de Almeida I; Wanders RJ; Ventura FV; Houten SM
    Biochim Biophys Acta; 2013 Sep; 1831(9):1467-74. PubMed ID: 23850792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective treatment in carnitine-acylcarnitine translocase deficiency.
    Pierre G; Macdonald A; Gray G; Hendriksz C; Preece MA; Chakrapani A
    J Inherit Metab Dis; 2007 Oct; 30(5):815. PubMed ID: 17508264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of carnitine acylcarnitine translocase deficiency by complementation analysis.
    Brivet M; Slama A; Ogier H; Boutron A; Demaugre F; Saudubray JM; Lemonnier A
    J Inherit Metab Dis; 1994; 17(3):271-4. PubMed ID: 7807931
    [No Abstract]   [Full Text] [Related]  

  • 8. Carnitine-acylcarnitine translocase deficiency: metabolic consequences of an impaired mitochondrial carnitine cycle.
    Röschinger W; Muntau AC; Duran M; Dorland L; IJlst L; Wanders RJ; Roscher AA
    Clin Chim Acta; 2000 Aug; 298(1-2):55-68. PubMed ID: 10876004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A patient with carnitine-acylcarnitine translocase deficiency with a mild phenotype.
    Morris AA; Olpin SE; Brivet M; Turnbull DM; Jones RA; Leonard JV
    J Pediatr; 1998 Mar; 132(3 Pt 1):514-6. PubMed ID: 9544911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to therapy in carnitine/acylcarnitine translocase (CACT) deficiency due to a novel missense mutation.
    Iacobazzi V; Pasquali M; Singh R; Matern D; Rinaldo P; Amat di San Filippo C; Palmieri F; Longo N
    Am J Med Genet A; 2004 Apr; 126A(2):150-5. PubMed ID: 15057979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carnitine-acylcarnitine translocase deficiency in three neonates presenting with rapid deterioration and cardiac arrest.
    Lee RS; Lam CW; Lai CK; Yuen YP; Chan KY; Shek CC; Chan AY; Chow CB
    Hong Kong Med J; 2007 Feb; 13(1):66-8. PubMed ID: 17277394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a short-chain carnitine-acylcarnitine translocase in mitochondria specifically related to the metabolism of branched-chain amino acids.
    Roe DS; Roe CR; Brivet M; Sweetman L
    Mol Genet Metab; 2000 Jan; 69(1):69-75. PubMed ID: 10655160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carnitine-acylcarnitine translocase deficiency: Two neonatal cases with common splicing mutation and in vitro bezafibrate response.
    Vatanavicharn N; Yamada K; Aoyama Y; Fukao T; Densupsoontorn N; Jirapinyo P; Sathienkijkanchai A; Yamaguchi S; Wasant P
    Brain Dev; 2015 Aug; 37(7):698-703. PubMed ID: 25459972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A patient with lethal cardiomyopathy and a carnitine-acylcarnitine translocase deficiency.
    Niezen-Koning KE; van Spronsen FJ; Ijlst L; Wanders RJ; Brivet M; Duran M; Reijngoud DJ; Heymans HS; Smit GP
    J Inherit Metab Dis; 1995; 18(2):230-2. PubMed ID: 7564255
    [No Abstract]   [Full Text] [Related]  

  • 15. [Analysis of four carnitine-acylcarnitine translocase deficiency cases caused by homozygous mutation of SLC25A20 c.199-10T> G].
    Fan X; Xie BB; Zhang Q; Yi S; Geng GX; Yang Q; Luo JS; Wang J; Li C; Chen SK; Shen YP
    Zhonghua Er Ke Za Zhi; 2018 Jul; 56(7):545-549. PubMed ID: 29996190
    [No Abstract]   [Full Text] [Related]  

  • 16. New insights into carnitine-acylcarnitine translocase deficiency from 23 cases: Management challenges and potential therapeutic approaches.
    Ryder B; Inbar-Feigenberg M; Glamuzina E; Halligan R; Vara R; Elliot A; Coman D; Minto T; Lewis K; Schiff M; Vijay S; Akroyd R; Thompson S; MacDonald A; Woodward AJM; Gribben JEL; Grunewald S; Belaramani K; Hall M; van der Haak N; Devanapalli B; Tolun AA; Wilson C; Bhattacharya K
    J Inherit Metab Dis; 2021 Jul; 44(4):903-915. PubMed ID: 33634872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial neonatal SIDS revealing carnitine-acylcarnitine translocase deficiency.
    Nuoffer JM; de Lonlay P; Costa C; Roe CR; Chamoles N; Brivet M; Saudubray JM
    Eur J Pediatr; 2000; 159(1-2):82-5. PubMed ID: 10653336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carnitine-acylcarnitine translocase deficiency, clinical, biochemical and genetic aspects.
    Rubio-Gozalbo ME; Bakker JA; Waterham HR; Wanders RJ
    Mol Aspects Med; 2004; 25(5-6):521-32. PubMed ID: 15363639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brief report: a deficiency of carnitine-acylcarnitine translocase in the inner mitochondrial membrane.
    Stanley CA; Hale DE; Berry GT; Deleeuw S; Boxer J; Bonnefont JP
    N Engl J Med; 1992 Jul; 327(1):19-23. PubMed ID: 1598097
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of L-aminocarnitine, an inhibitor of fatty acid oxidation.
    Chegary M; Te Brinke H; Doolaard M; Ijlst L; Wijburg FA; Wanders RJ; Houten SM
    Mol Genet Metab; 2008 Apr; 93(4):403-10. PubMed ID: 18077198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.